Aptiom Prices — US Pharmacy Cost vs Canada — Save Up to 90% in Canada

Our most recent US pharmacy data shows a low of roughly $57.04 for Eslicarbazepine Acetate with a standard discount card. That figure moves with dosage and quantity — check the comparison table for the exact combination you need.

Yes — Cost Plus Drugs lists Eslicarbazepine Acetate at roughly $9.72 per unit, a published price with no membership card or coupon involved. See the three-price comparison above for how that stacks up against discount-card pharmacies.

We found Canadian pricing for Eslicarbazepine Acetate starting near $1.00 per tablet in USD terms. That's before any shipping charge, which the table above breaks out separately.

Drug pricing is set separately in each country through different negotiation, regulatory, and distribution systems, so the same medication can legitimately carry different price tags on either side of the border. In this case, our data shows the Canadian price coming in lower — but that isn't true for every drug, so it's worth checking each medication individually rather than assuming.

The final cost of Aptiom with insurance depends entirely on the details of your specific plan, including formulary tier, deductible status, and copay or coinsurance structure. To get an accurate estimate, you should contact your insurance provider directly. Regardless of your insurance coverage, it can be beneficial to compare the copay against prices available through pharmacy savings programs, as these may sometimes offer a lower out-of-pocket cost than your standard insurance copay.

Yes, Aptiom is typically covered under Medicare Part D prescription drug plans and Medicare Advantage plans that include drug coverage. The patient's out-of-pocket cost will vary based on their plan's specific design and whether they are in the deductible, initial coverage, or coverage gap phase. Medicare copays for Aptiom can range widely. Patients are encouraged to use their plan's drug pricing tool and to inquire about all available savings options, which may include manufacturer copay assistance for eligible individuals, to help manage their medication expenses.

No, a generic version of Aptiom (eslicarbazepine acetate) is not currently on the market in the United States. It is only available as a brand-name medication.